Objective:To observe the clinical curative effect and safety of Xinyue capsule when it was used to treat qi deficiency and blood stasis type of coronary artery disease and congestive heart failure.Methods: 106 patients troubled by qi deficiency and blood stasis type of coronary artery disease and congestive heart failure from May 2007 to Oct.2009 were divided into treatment group and control group.They were treated with conventional therapy

and the treatment group was treated with Xinyue capsule at the same time.The heart functions were assessed 1 month later.Results: ①The total effective ratein treatment group 98.15%

88.46% in control group;② Color Doppler echocardiography in cardiac ejection fraction(EF): 36.11% before treatment

51.12% after treatment

P<0.05;The control group

36.41% before treatment

after treatment 42.31%

P <0.05;Cardiac diastolic volume(EDV):154.90 before treatment

after treatment 128.30

P<0.05;Control group

153.10 before treatment

after treatment 137.51

P <0.05;Cardiac systolic volume(ESV) 98.70 before treatment

after treatment 71.31

P <0.05;Control group 97.81 before treatment

after treatment 81.71

P<0.05.③Treatment groups of patients after treatment 6 min walking distance to improve more significantly.Conclusion: There is a satisfactory result by adding Xinyue capsule based on symptomatic treatment.Adverse effect isn’t observed.